Patent · US Active

Modified nucleotides methods and kits

US9828633B1 · kind B1 · utility

0Cited by

24References

23Claims

0Family size

Assignee

Pierce Biotechnology, Inc. · US

Inventors

Christopher L. Etienne · Fitchburg, US
Kay Opperman · Oregon, US
Barbara J. Kaboord · Oregon, US
Scott Meier · Rockford, US
Jean-Samuel Schultz · Rockford, US

Key dates

Filing date	Oct 15, 2015
Grant date	Nov 28, 2017
Priority date	—
Expiry date	Nov 25, 2035

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC12Y605/01003
WIPO fieldBiotechnology
WIPO sectorChemistry

Abstract

Modified nucleotides, and methods to modify nucleotides with a moiety or label, such as biotin, that permits their detection and results in a modified nucleotide, and methods of use of the modified nucleotide in quantitative and qualitative assays.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.